Cerebellar Ataxia Clinical Trials

26 recruitingLast updated: June 18, 2026

There are 26 actively recruiting cerebellar ataxia clinical trials across 21 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Paris, France, Dijon, France, Angers, France. Updated daily from ClinicalTrials.gov.


Cerebellar Ataxia Trials at a Glance

26 actively recruiting trials for cerebellar ataxia are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Paris, Dijon, and Angers. Lead sponsors running cerebellar ataxia studies include Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Assistance Publique - Hôpitaux de Paris, and Ataxia Study Group.

Browse cerebellar ataxia trials by phase

Treatments under study

About Cerebellar Ataxia Clinical Trials

Looking for clinical trials for Cerebellar Ataxia? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cerebellar Ataxia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cerebellar Ataxia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 26 trials

Recruiting
Not Applicable

Individualized Neuro-Modulation Paired With Cerebellar Therapy

Cerebellar AtaxiaCerebellar DiseasesCerebellar Stroke+1 more
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.30 enrolled1 locationNCT07642856
Recruiting

Natural History of Spinocerebellar Ataxia Type 7 (SCA7)

Spinocerebellar ataxia
National Eye Institute (NEI)25 enrolled1 locationNCT02741440
Recruiting

Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)

Spinocerebellar Ataxia Type 27B
University Hospital Tuebingen300 enrolled5 locationsNCT06472557
Recruiting
Not Applicable

Deep Brain Stimulation for Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 6Spinocerebellar Ataxia (SCA)
University of California, San Francisco5 enrolled2 locationsNCT07288437
Recruiting
Phase 1

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Spinocerebellar Ataxia Type 2
Arrowhead Pharmaceuticals36 enrolled16 locationsNCT06672445
Recruiting
Not Applicable

Autosomal Dominant Spinocerebellar Ataxias and Social Cognition

Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)
University Hospital, Angers160 enrolled1 locationNCT07099651
Recruiting
Not Applicable

The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias

Cerebellar Ataxias
Centre Hospitalier Universitaire Dijon210 enrolled1 locationNCT06467175
Recruiting
Phase 3

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

Spinocerebellar Ataxia 27B (SCA27B)
Assistance Publique - Hôpitaux de Paris70 enrolled9 locationsNCT07185347
Recruiting
Not Applicable

Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias

Spinocerebellar ataxia
University Hospital, Montpellier60 enrolled1 locationNCT07019558
Recruiting
Not Applicable

Retraining Reaching in Cerebellar Ataxia

Cerebellar Ataxia
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.18 enrolled1 locationNCT03879018
Recruiting
Phase 1Phase 2

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908
Recruiting
Not Applicable

Validation of the RADIAL Algorithm for Diagnosis of Autosomal Recessive Cerebellar Ataxia

Autosomal Recessive Cerebellar Ataxia
University Hospital, Strasbourg, France400 enrolled8 locationsNCT04261127
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Not Applicable

Enhancement of Quality of Work And Life

Parkinson DiseaseNeuromuscular Diseases (NMD)Mitochondrial Diseases+2 more
Radboud University Medical Center124 enrolled1 locationNCT06573866
Recruiting
Not Applicable

Evaluation of Urinary Dysfunction in CANVAS Patients

NeuropathyCerebellar AtaxiaVestibular Areflexia
Centre Hospitalier Universitaire de Nice40 enrolled3 locationsNCT06817707
Recruiting
Not Applicable

Home Exercise for Individuals with Neurodegenerative Disease

LeukodystrophyAtaxiaNeurodegenerative Diseases+5 more
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.30 enrolled1 locationNCT05443906
Recruiting
Not Applicable

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

Spinocerebellar ataxia
ALPS Biotech CO. LTD60 enrolled1 locationNCT06633003
Recruiting
Not Applicable

Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity

Spinocerebellar Ataxias
Chang Gung University40 enrolled1 locationNCT06600269
Recruiting

Hong Kong Spinocerebellar Ataxias Registry

Spinocerebellar ataxia
Chinese University of Hong Kong300 enrolled1 locationNCT03336008
Recruiting
Not Applicable

Electrical Stimulation Cycling Training Effects on SCA

Spinocerebellar Ataxia (SCA)
Chang Gung University145 enrolled1 locationNCT06363058